- NVO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $45.1 million.
- NVO traded 151,486 shares today in the pre-market hours as of 9:12 AM, representing 19.2% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in NVO with the Ticky from Trade-Ideas. See the FREE profile for NVO NOW at Trade-Ideas More details on NVO: Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. The stock currently has a dividend yield of 0.9%. Currently there are 2 analysts that rate Novo Nordisk A/S a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Novo Nordisk A/S has been 1.6 million shares per day over the past 30 days. Novo Nordisk A/S has a market cap of $151.7 billion and is part of the health care sector and drugs industry. Shares are up 35% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.